Expertise in
30
conditions

Dr. Hope M. Cottrill

Obstetrics and Gynecology
Baptist Health Medical Group-Palliative Medicine
1700 Nicholasville Rd Ste 1100, 
Lexington, KY 
Accepting New Patients
Expertise in
30
conditions
Baptist Health Medical Group-Palliative Medicine
1700 Nicholasville Rd Ste 1100, 
Lexington, KY 

Overview

Hope Cottrill is an Obstetrics and Gynecologist practicing medicine in Lexington, Kentucky.

Dr. Cottrill is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, Neuroendocrine Carcinoma of the Cervix, and Hysterectomy.

She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 6 clinical trials. Dr. Cottrill is currently accepting new patients.

Specialties

Obstetrics and Gynecology

Licenses

Internal Medicine in KY

Hospital Affiliations

Baptist Health Lexington
Baptist Health Richmond
Baptist Health Corbin

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Baptist Health Medical Group-Palliative Medicine
1700 Nicholasville Rd Ste 1100, Lexington, KY 40503

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women With Recurrent or Persistent Endometrial Cancer
A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women With Recurrent or Persistent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Procedure, Biological
Study Phase: Phase 2
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2026
Intervention Type: Drug, Procedure
Study Drugs: Carboplatin, Letrozole, Paclitaxel
Study Phase: Phase 3
A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma
A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma
Enrollment Status: Unknown
Publish Date: November 08, 2023
Intervention Type: Drug
Study Drugs: AL3818, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Carboplatin
Study Phase: Phase 3
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
View 5 Less Clinical Trials

4 Total Publications

Reloadable Stapler Use during Peripartum Hysterectomy for Placenta Accreta Spectrum: A Novel Surgical Technique and Case Series.
Reloadable Stapler Use during Peripartum Hysterectomy for Placenta Accreta Spectrum: A Novel Surgical Technique and Case Series.
Journal: American journal of perinatology
Published: August 21, 2020
Similar Doctors
Expertise in
35
conditions
Dr. Jennifer A. Fuson
Obstetrics and Gynecology
Expertise in
35
conditions
Dr. Jennifer A. Fuson
Obstetrics and Gynecology
Referral may be required
Before you request

Lexington Womens Health PLLC

1720 Nicholasville Rd Ste 702, 
Lexington, KY 
 (0.1 miles away)
859-264-8811
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jennifer Fuson is an Obstetrics and Gynecologist practicing medicine in Lexington, Kentucky. Dr. Fuson is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses Vaginal Bleeding Between Periods, Menorrhagia, Ovarian Cysts, Uterine Fibroids, and Intrauterine Device Insertion. Dr. Fuson is currently accepting new patients.

Expertise in
23
conditions
Dr. Bradley B. Youkilis
Obstetrics and Gynecology
Expertise in
23
conditions
Dr. Bradley B. Youkilis
Obstetrics and Gynecology
Referral may be required

Baptist Health Medical Group Ob/Gyn

1700 Nicholasville Rd Ste 704, 
Lexington, KY 
 (0.1 miles away)
859-278-0363
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bradley Youkilis is an Obstetrics and Gynecologist practicing medicine in Lexington, Kentucky. Dr. Youkilis is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Menorrhagia, Uterine Prolapse, Angiomyoma, Uterine Fibroids, and Intrauterine Device Insertion. Dr. Youkilis is currently accepting new patients.

Expertise in
22
conditions
Dr. Lynne O. Simms
Obstetrics and Gynecology
Expertise in
22
conditions
Dr. Lynne O. Simms
Obstetrics and Gynecology
Referral may be required

Baptist Health Outpatient Center At Georgetown

206 Bevins Ln, 
Georgetown, KY 
 (12.3 miles away)
502-868-0338
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lynne Simms is an Obstetrics and Gynecologist practicing medicine in Georgetown, Kentucky. Dr. Simms is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Angiomyoma, Uterine Fibroids, Ovarian Cysts, Neonatal Ovarian Cyst, and Intrauterine Device Insertion. Dr. Simms is currently accepting new patients.

Frequently Asked Questions about Dr. Hope M. Cottrill

How do I make an appointment with Dr. Hope M. Cottrill?

You can book an appointment with Dr. Hope M. Cottrill by calling their office at 859-278-5671. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Hope M. Cottrill a top-rated expert for Endometrial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hope M. Cottrill is classified as an Distinguished expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Hope M. Cottrill specialize in?

While Dr. Hope M. Cottrill is a Obstetrics and Gynecology, they have specific expertise in Endometrial Cancer, Cervical Cancer, and Malignant Mixed Mullerian Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Hope M. Cottrill participate in research or clinical trials?

Yes. Dr. Hope M. Cottrill has published 4 articles and abstracts on conditions like Endometrial Cancer. You can view a list of Dr. Hope M. Cottrill's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Hope M. Cottrill accept my insurance?

Dr. Hope M. Cottrill accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 859-278-5671 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cottrill's expertise for a condition
ConditionClose
    View All 24 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile